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Periprosthetic infections are a devastating complication of orthopedic procedures, costing 
time and money as well as the quality of life of affected patients. 13-93B3 is a boron-based 
bioactive glass that degrades and converts into hydroxyapatite when immersed in a physiological 
fluid. Its ability to break down and dissolve quickly would be useful for drug delivery when 
combined with bone cement because this glass can create passages in the cement that would 
increase the elution of incorporated antibiotics. The conversion of this bioactive glass into 
calcium phosphate products could also attract surrounding bone growth, further integrating 
implants with tissue and removing space on the cement surfaces where biofilms can form. While 
bioactive glasses have previously been added to bone cement, the incorporation of 13-93B3 into 
commercial bone cement has not yet been reported in literature. The focus of this study was to 
characterize composites of these materials by measuring its degradation rate and the identity of 
its resulting precipitate while monitoring for adverse reductions of mechanical strength. Particles 
of 13-93B3 with diameters of 5 μm, 33 μm, and 100 μm were mixed into a PMMA-based 
commercial bone cement, DePuy SmartSet MV, to create composites with 20%, 30%, and 40% 
glass loadings. The composites were formed into pellets and paired with bone cement control 
groups. These samples were soaked in phosphate-buffered saline (PBS). The compressive 
strength, Young’s modulus, water uptake, and weight loss of the pellets over time were recorded. 
The pH and boron concentrations of the solutions were measured at various soak durations. 
Results showed that smaller glass particles degraded faster in composites than larger particles, 
and that a higher amount of glass incorporation increased the amount of degradation that 
occurred. Composites with smaller glass diameters had higher compressive strengths than 
composites with larger glass particles, though the compressive strengths of all composites were 
found to be consistently above ASTM F451 and ISO 5833 standards. The conversion of 13-93B3 
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in the composites was studied using scanning electron microscopy (SEM), energy dispersive X-
ray spectroscopy (EDS), Fourier transform infrared spectroscopy – attenuated total reflection 
(FTIR-ATR), and micro-Raman spectroscopy. The solid precipitate that accumulated on the 
surfaces was determined to be hydroxyapatite incorporated with magnesium ions from the 
dissolved glass. The presence of this magnesium in the hydroxyapatite layer could improve the 
adhesion of the bone cement to living bone. Results from these tests suggest that composites 
made of 13-93B3 and bone cement may have a promising future in helping to prevent 
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Chapter 1: Introduction 
1.1. Burden of Prosthetic Joint Infections in the United States 
The cartilage in a person’s joint, such as in the hip or knee, can wear down over time. 
When this cartilage has degraded enough to cause pain and decreased mobility, the affected 
person can elect to undergo a joint arthroplasty to replace the damaged tissue with prosthetics. 
The main reason that this surgery is performed is to alleviate persistent pain from advanced 
arthritis that does not respond to less invasive measures.1  
While a joint arthroplasty can solve the initial problem, complications can arise. Of 
prosthetic implantation surgeries, infection is the second leading complication after aseptic 
loosening.2 In a study conducted in 2005 researching the reason that total knee replacement 
revisions occurred in 60,355 cases in the United States, the most common cause for a revision 
surgery was infection at 25.2%.3 In all joint prosthetic surgeries, the incidence of infection 
occurs between 1.0 to 3.0% of the time.4 Risk factors for developing infection include obesity, 
diabetes, rheumatoid arthritis, cancer, smoking, superficial infections at the surgical site, and 
using immunosuppressive medication.5,6 These comorbidities leave patients more susceptible to 
developing infections around the implant. 
Joint infections are distinguished from other complications using infection criteria, such 
as the development of a sinus tract next to the implant and bacterial growth in fluid cultures 
taken from the joint.6-8 Once the complication is diagnosed as a periprosthetic infection, an 
orthopedic surgeon performs a joint revision by reopening the site and removing the implants 
and surrounding tissue to clear away the bacterial infection. In a one-stage revision for total knee 
arthroplasties, after cleaning the infected site, new implants are placed into position during the 
same surgery. In a two-stage revision, which is the more common type of joint revision 
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performed in North America and is considered to be the more rigorous approach, after the 
infected implants are removed, a temporary spacer is placed into the patient where the implants 
had been.5,8 The patient is given intravenous antibiotics for six weeks and then rest without 
antibiotics for at least two more weeks while being monitored for further signs of infection. Once 
the infection is declared cleared, another surgery is performed to take out the spacer and install 
new implants.  Antibiotic-loaded bone cement is placed between the implant and the bone to help 
prevent a new infection.5,8,9 In 2007, the two-stage revision was reported to be more effective at 
clearing bacteria from the knee (91%) than the one-stage revision (81.1%).10 While a revision 
surgery may eliminate microbes, the quality of life for the patient can decrease. Twenty percent 
of patients in one study were unable to regain the functional use of their limb after a revision 
surgery.11 In patients undergoing joint revisions, the amount of bone left at the joint is reduced 
after each revision due to some bone being removed along with the infected implant. Therefore, 
the number of possible revisions that can be performed is finite. The inability to control the 
infection forces other options to be considered, such as removing the implants without replacing 
them (resection arthroplasty), fusing the joint into a fixed position (arthrodesis), or, when severe 
bone and tissue loss has occurred, amputation.5,8,12 
The average total cost of treating an infected joint in 2009 was $74,900 for knee patients 
and $93,600 for hip patients. In the same year, the cost of performing follow-up treatments to 
prosthetic hip and knee replacements was $566 million in the United States, and this number was 
expected to rise to $1.6 billion by 2020.13 A study was conducted in 2005 to follow the trends in 
knee and hip revisions in the United States from 1990-2003, and this research predicted that in 
2030, 572,000 hip arthroplasties and 3.48 million knee arthroplasties would be performed. Along 
with this, the study predicted that 96,700 hip revisions and 268,200 knee revisions would occur 
3 
 
in the United States in 2030, which would be a 174% and 601% increase from values seen in 
2005, respectively.14 Because of this forecasted rise in total surgeries, reducing the demand for 
revision surgery in the growing pool of arthroplasty patients would substantially lower healthcare 
costs in the future. 
 
1.2. Clinical Use of Bone Cement and Introduction to DePuy SmartSet Bone Cement 
Bone cement is a hard, inorganic polymer-based material used by surgeons as a grout to 
fill gaps in bone and around metal implants placed into joints. Various medical device companies 
create their own formulations of bone cement.15 Commercial bone cement is primarily made of 
poly(methyl methacrylate), known as PMMA, and contains other components in lesser amounts. 
These fillers are meant to improve the properties of the cement, such as by accelerating the 
polymerization of the PMMA and controlling its viscosity.16 The use of acrylic (PMMA-based) 
bone cement to anchor joint implants to bone was started by Charnley in the late 1950s and 
continues today.17 
One such commercial bone cement is DePuy SmartSet MV (DePuy, Warsaw, IN), the 
acrylic bone cement that will be studied in this thesis. SmartSet MV is packaged with a liquid 
and a solid component that forms a cement when mixed together. The liquid is composed of 98 
wt.% methyl methacrylate, the monomer of PMMA, and 75 ppm hydroquinone, which acts as a 
stabilizer for storage by inhibiting polymerization. The remainder of the liquid is N,N-Dimethyl-
p-toluidine, a curing activator.18 The solid component is 67.05 wt.% methyl methacrylate 
monomer; 21.1 wt.% methyl methacrylate/styrene copolymer, which are beads of pre-
polymerized material meant to increase fatigue strength; 1.85 wt.% benzoyl peroxide, a 
polymerization initiator; and 10 wt.% barium sulfate, a radiopacifier that increases the visibility 
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of the bone cement in x-ray images.19,20,21 Medical device companies aside from Depuy Synthes 
sell acrylic bone cements that contain similar ingredients in varying amounts.15 
To initiate PMMA polymerization, N,N-Dimethyl-p-toluidine from the liquid component 
of SmartSet MV interacts with the benzoyl peroxide in the powder and cleaves this molecule into 
two benzoates, creating free radicals in the process (Figure 1-1).16,22 Methyl methacrylate 
monomers then undergo free radical polymerization. Benzoyloxy radicals are the primary chain 
initiator, but the DMPT-related radical also contributes to initiation.23 As the polymer forms and 













Figure 1-1: The cleaving of benzoyl peroxide by N,N-dimethyl-p-toluidine to form radicals (A) and the free radical 
polymerization reaction of methyl methacrylate monomer into poly(methyl methacrylate) (B).16 
 
Antibiotics were first added to bone cement in 1969, and this combination has become 
the gold standard for antibiotic delivery when implant infection is a concern.16,24 In recent years, 
packaged bone cement already loaded with gentamicin or tobramycin have been sold in the US.25 
Other antibiotics, such as vancomycin to target MRSA, are also regularly added into bone 
cement in the surgical room in the hopes that the antibiotic will leach out of the cement and 
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prevent an infection from developing.5 The FDA only approves antibiotic-loaded bone cement 
for use in the final stage of a second-stage revision after the infection has been cleared, but some 
doctors have used antibiotic bone cement for primary total joint replacements in an attempt to 
more thoroughly prevent infections.26,27  
Despite its widespread use, antibiotic delivery using bone cement has limitations. Once 
the bone cement has been set in place and cured, an initial burst of antibiotic release occurs on 
the surface of the bone cement, and most of the remaining antibiotics typically become trapped 
in the cement.28 The release of antibiotics from cement is mainly a surface phenomenon, and 
antibiotics leave the cement through cracks and pores that have been penetrated by fluid 
surrounding the cement.29-31 After the initial release, only a small amount of antibiotics from 
within the cement is eluted, and this low concentration can allow for bacteria to develop a 
resistance against the antibiotic.32  
Bone cement also provides a foreign surface inside the body where opportunistic 
bacteria, such as Staphylococcus aureus that entered the body during the surgery, can form 
biofilms. Biofilms are extracellular structures of polysaccharides and proteins that bacteria exude 
that allow them to adhere to surfaces, and the biofilm forms a protective barrier for the bacteria 
from the body’s immune system and other external forces. Bacteria living within biofilms are 
more difficult to remove than free-floating bacteria through antibiotics.33 Along with being 
housed in a protective slime, some bacteria living deep inside a biofilm can grow slowly and 
avoid antibiotic mechanisms that exploit cellular growth, and bacteria in a biofilm are able to 
work together using quorum sensing (chemical signaling) to coordinate gene expression against 
antibiotics.34,35 The interface between acrylic bone cement and tissue tends to have either a gap 
or the presence of a fibrous tissue made in response to a foreign object in the body, which slows 
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down the immune response in that area and can allow bacteria to quietly fester in biofilms until it 
is too late for the immune system to clear out the bacteria on its own.36-38 Therefore, it is 
important to proactively eradicate bacteria before they are able to form protective biofilm 
hideouts and require more complex methods of treatment, such as joint revisions.  
Antibiotic delivery through acrylic bone cement itself has had challenges in preventing 
biofilm formation. Dunne et al. discovered that adding large amounts of gentamicin to Palacos R 
bone cement (Heraeus-Kulzer, Hanua, Germany) reduced bacteria viability for several hours, but 
this ultimately did not prevent biofilm formation from Staphylococcus aureus, and that adding as 
much as 2 grams of gentamicin to the cement caused the compressive strength of the cement to 
fall below the ASTM F451 standard of 70 MPa.39,40 Biofilms have also been found on 
gentamicin-loaded bone cement used clinically, meaning that they offer only a temporary 
avoidance of biofilms before their antibiotic elution rates are too low to suppress them.25,41 
Therefore, there is room for improvement to prevent biofilm formation on the surface of bone 
cement. 
 
1.3. Introduction to Bioactive Glass 
Bioactive glasses are resorbable materials that can degrade and convert into a 
hydroxyapatite-like material when in a physiological solution. Once inside the body, bioactive 
glasses attach to tissues and encourage growth from nearby bone due to their composition.42,43 
Bioactive glasses have been extensively researched as delivery carriers for antibiotics and 
nanoparticles.44-49 The first bioactive glasses were composed of silicate, and their compositions 
have been experimented with to improve their qualities. The original bioactive glass formulation, 
Bioglass 45S5, was created by Dr. Larry Hench in 1969 at the University of Florida.50 Bioglass 
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45S5 has been used in medical applications as a tissue scaffold.51 Another silicon-based 
bioactive glass, 13-93, contains other oxides that allow for easier manufacturing by increasing 
the temperature range that the glass can be molded, and this glass is approved for in vivo use in 
Europe and in the USA.52-54 The bioactive glass formulation S53P4 is particularly effective at 
eradicating a broad spectrum of bacteria, including Staphylococcus aureus and Staphylococcus 
epidermidis, which are common pathogens in periprosthetic infections.5,55 Bioactive glasses all 
have antimicrobial properties to some extent, however. Their mechanism of action is thought to 
be the increase in pH and osmotic pressure caused by the dissolution of alkali metals such as Na, 
which is not favorable for bacterial growth and may affect bacteria membrane potential.55 The 
optimal pH for most bacteria to form biofilms is 7, and deviations from this caused by bioactive 
glass can slow down biofilm formation.56 A faster degradation rate may increase the 
antimicrobial properties of a glass by raising the pH and ionic concentrations in solution higher, 
but this relation has not been shown conclusively in literature and is likely dependent upon the 
glass composition.57 
The degradation rate of a bioactive glass can be tailored by changing its composition. 
Increasing the ratio of boron to silicon causes the glass to degrade faster, which may be helpful 
for specialized applications.58-60 13-93B1 is a borosilicate bioactive glass manufactured in Mo-
Sci, Corp. in Rolla, Missouri, that is derived from 13-93 by replacing approximately one-third of 
the SiO2 in 13-93 with B2O3 (Table 1-1). The glass formulation that is the focus of this work is 
13-93B3, which is borate-based and is the result of replacing all SiO2 in 13-93 with B2O3. 13-





Glass Na2O K2O MgO CaO SiO2 B2O3 P2O5 Reference 
45S5 24.5 0 0 24.5 45 0 6 59 
S53P4 23 0 0 20 53 0 4 55 
13-93 6 12 5 20 53 0 4 59 
13-93B1 5.8 11.7 4.9 19.5 34.4 19.9 3.8 59 
13-93B3 5.5 11.1 4.6 18.5 0 56.6 3.7 59 
Table 1-1: Table of relevant glass formations by weight percentage. The glass formulation to be studied in 
this work, 13-93B3, is highlighted. 
 
1.4. Composition, Degradation, and Significance of Bioactive Glass 13-93B3 
13-93B3 is a bioactive glass that contains six different oxides with various purposes. 
Boron trioxide (B2O3), the matrix, makes up more than half of the glass’s weight (Table 1-1). As 
a supplement, boron also helps to promote cortical bone strength.62 Boron has been found to 
dissolve faster from glass than silicon does, and in an in vitro physiological environment, borate 
glass was also found to convert more completely into hydroxyapatite than silicate glasses.61 This 
dissolution process is assisted by sodium oxide (Na2O) and potassium oxide (K2O), which are 
network modifiers that break up the glass structure by influencing the boron network to contain 
BO4 units alongside BO3 units. Na and K are light alkali metals that are in turn hard acids, and 
these are able to stabilize the hard base BO4 electrostatically.63 The mixture of tetrahedral BO4 
and trigonal planar BO3 units in B2O3 is less durable than the tetrahedral units that make up SiO2, 
and so the borate-based 13-93B3 breaks down faster and more completely than glass with a 
tetrahedral silicate matrix does.51,61,64 Calcium oxide (CaO) is also a network modifier. Both 
calcium oxide and phosphorus pentoxide (P2O5) contribute calcium and phosphorus ions, which 
make up calcium phosphate and lead to the formation of hydroxyapatite. Magnesium, added in 
the form of magnesium oxide (MgO), is another network modifier.65 Magnesium also promotes 
bone remodeling and skeletal development, and magnesium deficiencies can cause bone 
fragility.65,66 The maintenance of calcium levels in bone are partly facilitated by magnesium, and 
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so magnesium helps to regulate bone density.67 Magnesium also encourages the adhesion of 
osteoblasts (bone-building cells) upon surfaces through an integrin-mediated mechanism, which 
would help attach bone to 13-93B3.68 
13-93B3 converts into hydroxyapatite when in a physiological solution, and this process 
takes several steps. First, Na+ dissolves from the glass structure, and the solution breaks down 
the B-O bonds in the matrix.61 Freed Ca2+ and PO43- from the glass as well as PO43- already in 
solution react to initially form amorphous calcium phosphate. Hydroxide (-OH) functional 
groups from the solution combine with the amorphous calcium phosphate layer, thus 
transforming the layer into hydroxyapatite. Carbonate (CO3-) functional groups from the solution 
and magnesium ions from the reacting glass can also become incorporated, forming carbonated 
hydroxyapatite with magnesium substitutions for calcium in its molecular structure.59,69 This 
non-stoichiometric hydroxyapatite would be similar to the type seen in natural bone, and this 
similarity can boost osteoconductivity when near living bone.70 
While 13-93B3 may be able to function as an antibiotic carrier, bioactive glasses such as 
13-93B3 are too brittle for any mechanical use on their own, much less for loading 
applications.36,71 In order to prevent an infection next to a joint prosthetic, 13-93B3 would need 
to be supported by a tougher material, such as bone cement. If added to antibiotic-loaded bone 
cement to create a composite and placed in a solution, bioactive borate glass 13-93B3 would 
degrade and form pathways for antibiotics to leave the bone cement. 13-93B3’s quality for 
attracting bone growth would also help integrate the bone cement with the body further and 






Antibiotic elution from PMMA-based bone cement is limited, and this is likely due to the 
occlusion of antibiotics in the cement. This low output wastes antibiotics and may give bacteria 
the opportunity to develop a resistance against the antibiotic. Adding a borate bioactive glass to 
antibiotic-loaded bone cement and allowing the glass to dissolve would create openings in the 
cement that would help release extra antibiotic material. The bioactive glass would also have the 
added effect of forming a hydroxyapatite-like material by providing calcium, phosphate, and 
magnesium into the solution that can precipitate back onto the bone cement’s surface. This 
precipitate, which is osteoconductive, would encourage bone growth around the bone 
cement.33 Integrating bone cement with living bone would reduce the open surface area on the 
cement that bacteria can potentially latch onto and help regenerate bone lost during surgery. 
This work is meant to assess the suitability of commercial bone cement and borate 
bioactive glass 13-93B3 composites as a bone cement alternative with an increased capacity for 
potential antibiotic release and bone attachment. This study combines 13-93B3 glass particles 
with SmartSet MV in various loading amounts and particle sizes and covers the following three 
chapters. Chapter 2 characterizes the mechanical strength of the composites before and after 
soaking in a saline solution by measuring the compressive strength and Young’s moduli of the 
samples and comparing these values to a control of bone cement containing no glass. The weight 
loss and water uptake of the samples were also measured to gauge the progression of glass 
degradation and to see how much water was entering the composites, which may reduce 
mechanical strength but also increase the transport of material out of the composites. The extent 
of the glass degradation was also measured using solution pH and ionic concentrations. Chapter 
3 encompasses work studying the morphology and identity of the white precipitate that 
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accumulated on the pellet surfaces over time. This was done using SEM to view the morphology 
of the precipitate, and three spectroscopy techniques (electron dispersive spectroscopy, Fourier 
transform infrared spectroscopy – attenuated total reflection, and micro-Raman spectroscopy) 
were used to identify the elements and molecular bonds in the material. Overall conclusions and 




Chapter 2: Characterization of the Degradation of Bone Cement and Boron-Based 
Bioactive Glass Composites 
2.1: Abstract 
Bone cement is used to fill gaps and attach prostheses to bone. Adding a resorbable 
bioactive glass to antibiotic-loaded commercial bone cements would potentially offer a means to 
increase drug elution while promoting local bone formation. This study characterizes the 
mechanical and degradation properties of composites containing commercial bone cement and the 
borate bioactive glass formulation 13-93B3, which can dissolve in physiological fluid. Here, 5 µm, 
33 µm, and 100 µm-diameter glass particles were each mixed with bone cement to create 20%, 
30%, and 40% glass-loaded mixtures. Mixtures and controls were soaked in phosphate-buffered 
saline (PBS). Compressive strength, Young’s modulus, weight loss, water uptake, solution pH, 
and ionic concentrations were measured for each group per soak duration. Compressive strengths 
of glass-loaded samples decreased over time but remained higher than the minimum ASTM 
standard of 70 MPa. The average Young’s modulus of the composites did not exceed 3 GPa. 
Weight loss and water uptake of samples did not extend beyond 2% and 6%, respectively. The pH 
and boron concentration of all solutions increased over time, and a higher percentage of glass 
loading resulted in a higher pH. Increases in pH and boron concentrations indicated that more glass 
converted into water-soluble alkaline products, such as NaOH. The composites used in this study 
showed signs of glass degradation without compromising their mechanical strength to the point of 
ineffectiveness. Future studies can examine the effects of incorporating antibiotics such as 
vancomycin into the composites and determine if the composites meet other ASTM standards for 





Bone cement is a material used by surgeons to fill gaps in bone and around metal 
implants placed into joints. Commercial bone cement is primarily made of poly(methyl 
methacrylate), or PMMA, and fillers are added to bone cement to initiate polymer 
polymerization, to increase the radiopacity of the cement, and to increase its shelf life.16 One 
downside of bone cement is that this material can provide a place of attachment for the biofilms 
of infectious bacteria.72 Systemic antibiotics can be given intravenously as an extra layer of 
prophylaxis, but the concentration of antibiotics at the surgical site from this method alone may 
be too low to fight bacteria off and may be toxic to other areas of the body.73 Delivering 
antibiotics locally instead can introduce high amounts of antibiotics that can kill bacteria that 
would otherwise be resistant to lower systemic antibiotic concentrations, and this delivery 
system can also introduce antibiotics into avascular areas that are not accessible to systemic 
antibiotics.74 bone cement is routinely mixed with antibiotics to combat bacteria in this way, but 
some of the antibiotics become trapped in the PMMA matrix and do not leave the cement, which 
wastes material.15,28 
Despite this, in 1995, 90% of orthopedic surgeons manually added antibiotics to bone 
cement to prevent infections, and by 2004, several premixed low-dose antibiotic cements had 
been approved by the FDA for use in the second stage of a two-stage revision after the infection 
had cleared.27,30 The release method of antibiotics from bone cement has been under debate, but 
the general consensus is that the release mechanism is a surface phenomenon.31 After an 
antibiotic-loaded bone cement is immersed in a liquid, an initial release burst of antibiotics at the 
surface of the bone cement occurs, followed by a longer release of low amounts of antibiotics.32 
This amount may be too low to inhibit the growth of bacteria and may instead allow resident 
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bacteria to develop a resistance, rendering the antibiotic ineffective and requiring a different 
method to clear out the infection.26  
Beads of antibiotic-loaded PMMA have been used clinically to locally deliver antibiotics 
to a joint. However, these beads are normally removed surgically soon after implantation to 
prevent release rates that are too low to fight bacteria.41,75 In one study, only 35% of the 
antibiotics inside commercial Septopal beads (Biomet Merck, Darmstadt, Germany) were found 
to have eluted after 45 days.28 In another study, routine culture tests showed that PMMA beads 
loaded with gentamicin appeared to eradicate bacteria in patients, but Neut et al. discovered 
through more rigorous laboratory testing and scanning electron microscopy (SEM) that the 
PMMA beads were covered with bacteria.76 They later discovered a clinical case of gentamicin-
loaded beads still eluting gentamicin in a patient five years after implantation.41 Tunney et al. 
also discovered gentamicin-resistant bacteria on infected hip implants that were cemented using 
gentamicin-loaded bone cement.25 These findings suggest that the eventual sub-inhibitory release 
rate of antibiotic-loaded bone cement could allow for infectious bacteria to develop a resistance 
against the antibiotic and flourish again. 
As composites, acrylic bone cement has previously been combined with bioactive glasses 
in literature, and this is usually meant to improve the cement’s bone-binding ability and its 
mechanical properties. Bioactive glasses are materials that can degrade in a physiological 
solution and release ions helpful for bone growth.57 While these glasses can potentially increase 
antibiotic release from bone cement by creating pores, adding a new material such a dissolvable 
glass can affect the mechanical integrity of the bone cement, and so its mechanical properties 
should be watched. In literature, adding bioactive glass to PMMA does not seem to initially 
weaken the PMMA, however. Shinzato et al. added a silicate-based bioactive glass with average 
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particle diameter ranges of 4, 5, 9, and 13 µm to PMMA and tested the glass’s effect upon the 
cement’s mechanical properties and osetoconductivity.77 They found that cement composites 
with smaller glass particle sizes had higher bending strengths and a higher affinity to bone than 
did composites with larger glass particles. The same group also tested the effect of glass loading 
amounts of 40%-70% upon the mechanical strength of PMMA, and increases in the loading 
amount correlated with increases in the bending strength and bone affinity of the cement.78,79  
PMMA has also been mixed with both bioactive glass and antibiotics and studied in the past. 
Arcos et al. added gentamicin sulfate to a mixture of a silicate-based glass and PMMA and 
determined that the addition of PMMA and antibiotics did not affect the bone-binding ability of 
the glass.80 Fernández et al. found that adding 60-70 wt.% phosphate-based glass to PMMA 
increased the amount of vancomycin released from the cement.81  
While bioactive glasses have been mixed into PMMA before, the interactions between 
bioactive glass 13-93B3 (mol%: 6 Na2O, 7.9 K2O, 7.7 MgO, 22.1 CaO, 54.6 B2O3, 1.7 P2O5) and 
a PMMA-based cement have not been studied. Like other bioactive glasses, 13-93B3 can 
dissolve and convert into a hydroxyapatite-like substance over time within the human body’s 
environment. Borate glasses such as 13-93B3 differ from more common silicate-based bioactive 
glasses, however, by degrading faster and more completely.61 13-93B3’s main elemental 
component is boron, which make up the matrix in the form of B2O3. This glass also contains 
potassium and sodium, which help to break up the matrix for quicker dissolution. Calcium and 
phosphorous in the glass contribute the building blocks of calcium phosphate and 
hydroxyapatite. Magnesium, an element that assists with bone growth, is also included.65  
If 13-93B3 is mixed into bone cement and encounters a physiological fluid, then this 
glass can dissolve and create openings in the cement, allowing a way for antibiotics within the 
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cement to enter the solution. This added porosity of the cement would potentially increase the 
amount of antibiotic delivery.82 Because of its fast-acting and thorough degradation, 13-93B3 
incorporated into the commercial bone cement could be able to both deliver material at a joint for 
bone growth while creating pathways in the cement for extra future antibiotic elution. 
This work characterizes the mechanical properties of composites of borate-based 
bioactive glass 13-93B3 and bone cement by measuring their compressive strengths and Young’s 
moduli over time spent soaking in phosphate-buffered saline (PBS). Adding a biodegradable 
material into bone cement would create voids in the cement over time, which would allow for 
further elution of glass components and potentially antibiotics. However, this may decrease the 
mechanical strength of the cement to below the compressive strength ASTM standard of 70 MPa 
and cause the bone cement to become undesirable for weight-bearing applications.40 Because of 
this standard, the compressive strength of the composites must be monitored. The Young’s 
(elastic) modulus of the composites is also important to assess because an implant with a 
modulus considerably higher than the modulus of interfacing bone can cause the bone to degrade 
due to stress shielding.83 The Young’s modulus of cortical bone and cancellous bone is 3-30 GPa 
and 200-500 MPa, respectively, and in one canine study, the use of a bone cement with a 
Young’s modulus of 9.7 GPa caused bone reabsorption.84,85 The weight loss and water uptake of 
the composites were also studied because these measures reflect the amount of water penetration 
into the pellets. Water uptake can negatively affect mechanical properties by degrading the bone 
cement itself, though some water uptake is needed to help transport glass material out of the 
composite.15,18,86 pH and the ionic concentrations of B, Mg, and P were measured over time from 
the phosphate-buffered solutions that immersed the composites, as these also relate to the 
degradation of the bioactive glass. The glass components that enter the solution undergo 
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hydrolysis through the following primary reactions: Na2O + H2O  2NaOH, K2O + H2O  
2KOH, MgO + H2O  Mg(OH)2, CaO + H2O  Ca(OH)2, B2O3 + 3H2O  H3BO3, and 2P2O5 
+ 6H2O  H3PO4. The first four products are strong bases, and the last two are weak acids. The 
strong bases would contribute hydroxide anions that elevate the solution pH. As the glass 
continues to dissolve, the pH will increase, and therefore pH can be used as an indicator of the 
progression of the degradation of the glass and its transportation into the solution.55 The 
concentration of ions originating from the glass would also increase in solution as the glass 
degrades. Rises in boron concentration can be used to determine glass degradation, and this 
would be the ion of choice because calcium, phosphorus, and magnesium ions are more readily 
incorporated into precipitated compounds, and potassium and sodium would already exist in the 
PBS (phosphate-buffered saline) solution to be used.87,88 
 
2.3. Materials and Methods 
2.3.1. Materials 
DePuy SmartSet MV (DePuy, Warsaw, IN) was used as the commercial bone cement. 
SmartSet MV is packaged with a liquid and a solid component that forms a cement when mixed 
together. The liquid is comprised of 98 wt.% methyl methacrylate with 75 ppm hydroquinone, a 
stabilizer for storage. The remainder is N,N-Dimethyl-p-toluidine, a curing activator.6 The solid 
component is 67.05 wt.% poly(methyl methacrylate) monomer; 21.1 wt.% methyl 
methacrylate/styrene copolymer, a hydrophobic fatigue strengthener; 1.85 wt.% benzoyl 
peroxide, a polymerization initiator; and 10 wt.% barium sulfate, a radiopacifier that causes the 
bone cement to be visible in x-rays.7,18,20 The methyl methacrylate monomer in the liquid reacts 
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with the powder PMMA in the solid component through free radical polymerization to form 
bone cement. 
Bioactive glass particles were obtained from Dr. Mohamed Rahaman from Missouri 
University of Science and Technology. Glass with the formulation of 13-93B3 (mol%: 6 Na2O, 
7.9 K2O, 7.7 MgO, 22.1 CaO, 54.6 B2O3, 1.7 P2O5) was prepared by mixing Na2CO3, K2CO3, 
MgCO3, CaCO3, NaH2PO4 • 2H2O, and H3BO3 (Fisher Scientific) together and heating the 
mixture at 1100°C for 1 hour inside of a platinum crucible. The material was then quenched 
between cold steel plates.  
Three particle sizes of glass were prepared and designated as 5 µm, 33 µm, and 100 µm. 
The 5 µm size was used because this diameter is within a range often seen in literature.44,53,57,79,89  
100 µm particles were also used because some studies have used glass particles >100 µm and 
because resultant pores with a diameter of at least 100 µm would allow for better tissue 
ingrowth.61,90,91 The medium size, 33 µm, was picked by the recommendation of Dr. Mohamed 
Rahaman for having a glass surface area in between the surface areas of 5 µm and 100 µm glass 
particles.  
To prepare the 100 µm glass, 200 grams of glass frits were weighed and ground for 30 
seconds in a steel shatterbox (8500 Shatterbox, Spex SamplePrep LL, Metuchen, NJ). The glass 
was then sieved through stainless steel sieves, leading to a range of particle sizes between 75 µm 
and 106 µm. To create the 33 µm size, 100g of glass frits were weighed and ground for 150 
seconds in the steel shatterbox. Through particle size analysis (Microtrac S3000 particle size 
analyzer), the glass was found to have an average size of 33 µm with a standard deviation of 19 
µm. The 5 µm size was created by weighing and grinding 100 grams of glass frits for 150 
seconds in the steel shatterbox. The glass was then additionally ground for 90 minutes in an 
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attrition mill (Model 01-HD, Union Process, Akron, OH), using high-purity Y2O3-stabilized 
ZrO2 as the milling media and ethanol as the solvent. Once dry, the glass was lightly ground with 
a mortar and pestle and then sieved though a 106 µm stainless steel sieve. Particle analysis 
determined that the glass had a particle size of 5 µm with a standard deviation of 3 µm. The 
particles were prepared at Mo-Sci Corp. (Rolla, MO).  
The solution used in the following experiments was phosphate-buffered saline, which is 
also known as PBS (Ricca Chemical Company). PBS is an isotonic solution used in biological 
research.18 Table 2-1 provides the weight percentages of components in the PBS solution used.  
 
Component H2O NaCl Na2HPO4 KH2PO4 KCl 
wt.% 99.02 0.08 0.14 0.03 0.02 
Table 2-1: The composition of the PBS formula used. 
 
2.3.2. Methods 
2.3.2.1. Cement preparation 
To create pellet samples, the solid component of the bone cement was poured into a bone 
cement mixing bowl that was connected to a vacuum source. Powdered 13-93B3 glass was then 
added to the bowl and mixed with the bone cement powder. The liquid bone cement component 
was then added, and the bowl was closed with a lid. The vacuum source was turned on, and the 
cement was mixed at 1 Hz for 90 seconds. Afterwards, the vacuum source was turned off and the 
lid was then opened, and the cement was then touched with a gloved finger to check the 
consistency of the cement. The cement was mixed in air with a spatula for 15 more seconds, after 
which the cement consistency was checked again. The doughing time was defined as the length 
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of time between the beginning of the mixing and when the dough no longer formed strands when 
touched by a gloved finger.  
After reaching doughing time, the cement was then pressed into polytetrafluoroethylene 
(PTFE) molds to form cylinders 12 mm tall with diameters of 6 mm. A PTFE plate was placed 
under the mold and the cement was pressed into the molds. Another PTFE plate was placed over 
the molds, and the plates were held in place around the mold using a C-clamp. The mold was 
then placed inside an incubator with a temperature of 37°C for one hour. 
Afterwards, the bone cement pellets were pressed out of the molds and weighed. The 
pellets were then individually placed into 15-mL polypropylene tubes containing 2.5 mL PBS. 
After 0, 1, 3, 7, and 21 days of soaking, the pellets were removed from the PBS and further 
tested upon. 
Ten different compositions of glass-incorporated bone cement were made, and their 
formulations and name designations are listed in Table 2-2. The percentages in their names are 
the percentages of glass that composed the dry material (SmartSet MV powder with glass) before 
becoming mixed with the liquid component. Glass loading amounts of 20%, 30%, and 40% were 
used because these were moderate values within the range used in literature. In studies of 
bioactive glass and bone cement composites, glass loading amounts have ranged from 4% to as 






















Control 0 40 0 18.88 0 
20% 5 µm 20 40 10 18.88 14.5 
30% 5 µm 30 40 17.14 18.88 22.5 
40% 5 µm 40 40 26.67 18.88 31.2 
20% 33 µm 20 40 10 18.88 14.5 
30% 33 µm 30 40 17.14 18.88 22.5 
40% 33 µm 40 40 26.67 18.88 31.2 
20% 100 µm 20 40 10 18.88 14.5 
30% 100 µm 30 40 17.14 18.88 22.5 
40% 100 µm 40 40 26.67 18.88 31.2 
Table 2-2: The mixing compositions of the glass-loaded bone cement groups used. 
 
2.3.2.2. Mechanical Testing 
Using an MTS Mini Bionix 858 load frame (MTS Systems Corporation, 14000 
Technology Drive, Eden Prairie, MN), the compressive strengths of unsoaked samples were 
tested 24 ± 2 hours from the beginning of mixing time as well as after 1, 3, 7, and 21 days of 
soaking. Samples were crushed at a loading rate of 20 mm/min to either 40% strain or at fracture, 
whichever occurred first. Here, fracture was considered to have occurred when the loading fell to 
90% of its peak value. The compressive strength of the pellets is the failure load divided by the 
cross-sectional area of the pellets. ASTM F451 defines the failure load as the load at the 2.0% 
offset from the elastic section of the stress-strain curve, the ultimate yield load, or the load at 
fracture, whichever occurred first. The ASTM F451 and ISO 5833 standard for the compressive 
strength of acrylic bone cement is a minimum of 70 MPa after 24 ± 2 hours from the beginning 
of cement mixing.40,93 Glass mixtures were paired with controls that were tested at the same 
time. Five samples were tested from each group except where noted. 
Young’s modulus is the elastic stiffness of a sample and is numerically the slope of the 
elastic section of a sample’s stress-strain curve. This value was collected alongside the 
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compressive strength by MTS Series 793™ Control Software (MTS Systems Corporation, 14000 
Technology Drive, Eden Prairie, MN) at 20 Hz. 
 
2.3.2.3. Water Uptake 
After soaking in PBS for a designated amount of time, pellets were removed from the 
solution with tweezers and rinsed with deionized water to remove excess PBS from the pellet 
surfaces. The pellets were then blotted with KimWipes (Kimberly-Clark, Irving, TX) and 
weighed. The water uptakes of the pellets were calculated using the following equation: 
 
𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊 𝑈𝑈𝑈𝑈𝑊𝑊𝑊𝑊𝑈𝑈𝑊𝑊 =  �
𝑚𝑚𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 −  𝑚𝑚𝑓𝑓𝑓𝑓𝑓𝑓𝑖𝑖𝑓𝑓𝑓𝑓𝑓𝑓
𝑚𝑚𝑓𝑓𝑓𝑓𝑓𝑓𝑖𝑖𝑓𝑓𝑓𝑓𝑓𝑓
�  𝑥𝑥 100% 
 
where minitial is the initial weight of the pellet after being removed from the molds, and mfinal is 
the weight of the pellet after being rinsed in deionized water. This experiment was performed in 
triplicate, and glass mixtures were paired with controls that were tested at the same time. 
 
2.3.2.4. Weight Loss 
After the water uptake of the pellets were measured, the pellets were placed in 
histological glass jars, which were then placed on an autoclave tray and kept in an oven set to 
90°C. After one day, the pellets were weighed again. The weight losses of the pellets were 
calculated using this equation: 
 
𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑊𝑊 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 =  �
𝑚𝑚𝑑𝑑𝑑𝑑𝑑𝑑 −  𝑚𝑚𝑓𝑓𝑓𝑓𝑓𝑓𝑖𝑖𝑓𝑓𝑓𝑓𝑓𝑓
𝑚𝑚𝑓𝑓𝑓𝑓𝑓𝑓𝑖𝑖𝑓𝑓𝑓𝑓𝑓𝑓




where minitial is the weight of the pellet after being removed from molds, and mdry is the weight of 
the pellets after being taken out of the oven. This experiment was performed in triplicate with the 
same samples studied for their water uptake. 
 
2.3.2.5. pH and Ionic Concentration 
The pH values of the solutions were found by combining the solutions from three pellets 
and recording the pH of the combined solutions with a Fisher Scientific accumet™ AB15 Basic 
(Thermo Fisher Scientific, Waltham, MA) pH meter. 
To gather ionic concentration data, the solutions that were used with the pellets for 
weight loss and water uptake tests were diluted with water and nitric acid to become a 2 v/v%  
nitric acid solution. This was analyzed with ICP-OES using a Jobin-Yvon JY 138 Ultrace 
(Horiba Jobin Yvon, Inc., 3880 Park Ave, Edison, NJ). To dilute the solutions, 2.5 mL of 2 M 
nitric acid was added to the vial of each sample solution. The mixture was then vortexed. 
Afterwards, 1.6 mL of the mixture was added to 30.2 mL of DI water in a 50-mL vial. Then, 8.2 
mL of 2 v/v% nitric acid was slowly added. A sample of diluted PBS was used as the Day 0 
reading for the ionic concentrations in each group. This experiment was performed in duplicate 
except for 20% 100 µm, which does not have a Day 1 and has a sample size of n=1 for Day 22. 
Ionic concentrations were not collected for 33 µm samples due to limited equipment availability. 
The magnesium concentrations relative to the boron concentrations in solution over time 
were computed for the groups tested. This ratio was normalized to the magnesium-to-boron 
weight ratio in 13-93B3’s formulation (15.78%). For this comparison, Day 0 concentrations were 
subtracted from the data so that only magnesium and boron originating from the glass was 
represented. If the glass dissolved congruently and remained in solution, meaning that the 
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relative amounts of boron and magnesium that dissolved were the same as their proportional 
amounts in the glass, then the ratio would have a value of one. A value greater than one would 
mean that more magnesium was in solution than would be expected based on the amount of 
boron in solution, and a value less than one would mean that less magnesium is in solution than 
would be expected from the boron concentration. 
 
2.3.2.6. Statistical Analysis 
 To perform statistical analysis upon the pellets for compressive strength, Young’s 
modulus, weight loss, and water uptake, composites and controls tested at the same time were 
treated as separate blocks and were compared against each other. This was done to control for 
environmental variability that would otherwise confound the results, as different composite 
groups were tested on different days. To increase graph readability, the shown control data for 
each day in Figures 2-1, 2-2, 2-3, and 2-4 was the result of combining the controls for all loading 
amounts. See the appendix for the extended versions of these figures which show all composite 
and control comparisons.  
The ± 1 sample standard deviation of each group is shown in the data where possible. 
Levene’s test was performed to check the equality of variances between glass-bone cement 
composites and their respective controls. Unpaired t-tests were then performed upon the 
compressive strength, modulus, weight loss, and water uptake data with equal variance. 
Comparisons involving unequal variances were made using Welch’s t-test. Composites were 
considered significantly different from their respective controls if p <0.05. The analysis was 




A propagation of uncertainty calculation was performed to report the ± 1 standard 





















where “s” is the sample standard deviation and “Mg” and “B” are the concentrations of 
magnesium and boron, respectively. 
 
2.4. Results 
2.4.1. Compressive Strength 
The compressive strengths of the composites and the controls after various soaking durations are 
shown in Figure 2-1. In all cases, the compressive strengths of the samples did not fall below 70 
MPa. When significantly different from their respective controls, 5 µm glass composites had a 
higher compressive strength than the control, and 33 µm and 100 µm glass composites had lower 
average compressive strengths than their controls. Increasing the loading amount of 5 µm glass 
appeared to raise the compressive strength of the glass, while increases in the amount of 100 µm 
glass lowered the compressive strength. The 40% 33 µm group for three days of soaking had a 
sample size of n=4 due to a deficit of well-formed samples. The last 30% 5 µm group soaked for 




Figure 2-1: The compressive strengths of 5 µm (A), 33 µm (B), and 100 µm (C) composites and their respective 
cement controls. The control is the average of all controls tested at each time duration (n=15). The lines intersecting 
the graphs correspond to 70 MPa, the minimum standard from ASTM F451 and ISO 5833. A diamond (♦) 
represents a group that soaked for 20 days. A triangle (▲) represents a group of n=4. An asterisk (*) represents a 
significant difference (p<0.05) from the control set (n=5) that each group (n=5) was tested against (not shown). 
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2.4.2. Young’s Modulus 
Figure 2-2 shows the Young’s modulus of the composites and the controls after soaking. 
When significantly different from their respective controls, 5 µm glass composites had higher 
moduli than their respective controls, and 33 µm and 100 µm glass composites had lower moduli 
than their control counterparts. The moduli of samples slightly decreased over soak time, and the 
averages decreased more over soak time as the loading amount was raised. The highest average 
Young’s modulus value, which was for 30% 5 µm without soaking, did not go beyond 3%. 
Young’s modulus was collected from the same pellets used to record compressive 
strength, and so the 40% 33 µm group after three days of soaking had a sample size of n=4 and 





Figure 2-2: The Young’s modulus of 5 µm (A), 33 µm (B), and 100 µm (C) composites and their respective cement 
controls. The control is the average of all controls tested at each time duration (n=15). A diamond (♦) represents a 
group that soaked for 20 days. A triangle (▲) represents a group where n=4. An asterisk (*) represents a significant 




2.4.3. Weight Loss  
Figure 2-3 shows that the weight loss of the control samples consistently stayed under 1% 
of their original weights after soaking and drying. All composites lost weight within the first 
week of soaking, but their average weight loss did not exceed 1.5% of their original weight. 
Some groups gained weight between 7 and 21 days, and these were the 33 µm groups and the 
20% and 30% 5 µm groups. Whenever the composites were significantly different from the 
control, all composites except for 20% 33 µm samples had a lower weight loss than the control 




Figure 2-3: The weight loss of 5 µm (A), 33 µm (B), and 100 µm (C) composites and their respective cement 
controls. The control is the average of all controls tested at each time duration (n=9). An asterisk (*) represents a 
significant difference (p<0.05) from the control set (n=3) that each group (n=3) was tested against (not shown). 
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2.4.4. Water Uptake 
From the water uptake data seen in Figure 2-4, all composites retained more water than 
their control counterparts, and their average water uptake generally increased as soak time 
lengthened. For 33 µm and 100 µm composites, the 40% loaded version contained the most 
water after 21 days. 20% 100 µm was the only group to not uptake a significantly higher amount 




Figure 2-4: The water uptake of 5 µm (A), 33 µm (B), and 100 µm (C) composites and their respective cement 
controls. The control is the average of all controls tested at each time duration (n=9). An asterisk (*) represents a 




The pH of the solutions were collected and shown in Figure 2-5. The pH values increased 
as the amount of glass increased and as the particle diameter size decreased. For solutions 
containing controls, the pH decreased slightly over time. The control values shown in Figure 2-5 




Figure 2-5: The pH of solutions for composites containing 5 µm (A), 33 µm (B), and 100 µm glass (C) with 




2.4.6. Ionic Concentration 
The concentration of boron in solution increased as the glass particle size decreased and 
as the loading increased, which is shown in Figure 2-6. A higher glass loading appeared to 
increase the overall elution of boron. After 21 days, the difference between the boron 
concentrations from 30% and 40% glass mixtures were larger than the difference between 20% 
and 30% glass mixtures. For boron, 20% 5 µm had concentrations close to the concentrations of 
40% 100 µm over time. The rates of boron and magnesium elution appeared to slow down over 
time, but more of both ions were still accumulating after 21 days, especially for 40% 5 µm.  
Figure 2-7 shows the magnesium concentration relative to the boron concentration and 
normalized to the magnesium-to-boron weight ratio in 13-93B3’s formulation. Less magnesium 
was in solution than would have been expected in a congruently-dissolving glass, and this was 
more pronounced for 5 µm groups. 
The data for 20% 100 µm is shifted forward in time from the rest of the groups due to 
temporary logistics issues, and the ionic concentrations of calcium is not reported here due to 
recording errors. Composites containing 5 µm glass had lower Mg/B concentration ratios than 
composites with 100 µm glass. Composites with glass loading amounts of 40% also had the 





   
Figure 2-6: The ionic concentrations of B, Mg, and P over time in PBS (n=2). For 20% 100 µm, Day 2 is shown 




Figure 2-7: The Mg/B ratio of ionic concentrations over time in PBS, normalized to their original elemental weight 





After the samples soaked in PBS, the composites with more than 20% glass loading 
showed signs of a white precipitate accumulating upon the surfaces while the controls did not 
look appreciably different from when they were cured. Therefore, physical changes to the 
composites over time due to the addition of the glass were visibly apparent.  
Adding 13-93B3 particles to the PMMA strengthened the bone cement initially, but 
because the bioactive glass dissolved over time, the compressive strengths of the samples 
dropped as the soaking length increased. The decrease in compressive strength over time spent 
soaking was more evident for larger loading amounts. This was likely due to increased water 
penetration around the glass and because more glass was available to interact with the PBS. The 
same trend was seen for 100 µm composites. For 5 µm composites, the 30% and 40% glass 
loadings had a higher compressive strength than the control, while composites containing 33 µm 
particles had an initial average compressive strength less than the average of the control. This 
meant that the 33 µm glass size did not bond as well to the bone cement as the 5 µm composites 
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did and therefore created areas of stress concentrations.94 The lack of change in compressive 
strength for 20% 100 µm composites was most likely due to the low amount of glass surface area 
exposed to the PBS to undergo dissolution. The increase in compressive strength for 30% and 
40% loadings of 5 µm glass after one day of soaking correlated well with the rise in strength 
seen by Shinzato et al., which used a silicate glass with an average particle size of 3.2 µm at 
those loading amounts.79 The increases in the same groups seen with no soaking also correlated 
with the compressive strength rises in 30% and 40% borate glass-loaded PMMA documented by 
Lopes et al.18 
The Young’s moduli for the 5 µm composites was higher than the moduli of their 
respective controls, and this may have been because the 5 µm glass particles bonded well with 
the bone cement. The composites with larger particle sizes had lower moduli than their controls 
because their bigger size got in the way of the polymerization process.95 As with the compressive 
strength, increases in the Young’s modulus for 30% 5 µm and 40% 5 µm after one day of 
soaking relative to their controls followed the trend seen by Shinzato et al. for similar 
composites.79 Because the borate glass dissolved while soaking, the Young’s modulus typically 
dropped over time. This effect was increased for formulations with higher concentrations of 
glass, and this was likely because more glass was available to dissolve, causing a larger decrease 
in stiffness.  
The Young’s modulus of a suitable bone cement should be low enough to be similar to 
bone’s modulus so that stress shielding does not occur around stiff implants and cause 
surrounding bone loss.83 For comparison, the Young’s modulus of cortical bone is 3-30 GPa, and 
the Young’s modulus of cancellous bone is 200-500 MPa.84 Composite moduli was 
approximately 1.5-3 GPa, which is between the moduli of cortical and cancellous bone and is 
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less than the reported Young’s modulus value to cause reabsorption.85 Therefore, this suggests 
that the cement would not have a strong moduli mismatch issue with bone. 
The average weight loss of pellets did not exceed 2%, which is similar to the weight 
losses seen in glass/PMMA composites previously reported by Lopes et al.18 Notably, the weight 
losses seen in their work for PMMA, ~0.7%, is nearly identical to the values seen here for the 
bone cement control.18 Increases in weight loss over time is likely due to the material in the glass 
leaching away from the pellet, and decreases in weight loss may be attributed to the 
accumulation of solid precipitate from the solution upon the pellet surface.18 This cannot 
sufficiently explain the low weight loss seen in 20% and 30% 5 µm samples after 21 days of 
soaking, however. These pellets may have still contained water after the drying period, and a 
larger sample size would have made these readings more robust. Weight loss seen from the 
control could be from loose material detaching from the sample while soaking. 
The average water uptake of the composites generally increased as soak time lengthened, 
meaning that the pellets were continually approaching but not reaching water saturation 
throughout the experiment. Therefore, water penetration into the pellets continually progressed 
over time past at least seven days.18 Commercial bone cement has been shown to uptake water 
by less than 3 wt.%, and here water uptake did not exceed 6 wt.% for all composites.18 An 
increased water uptake is correlated with a decrease in compressive strength, but this property 
may also cause the bone cement to expand and press into the surrounding implant and bone, 
stabilizing them further.96 As predicted by the increase in water uptake, the compressive strength 
and Young’s moduli of the composites did decrease over time spent soaking, but these drops 
were not enough to violate ASTM standards. As 13-93B3 is more hydrophilic than PMMA, 
composites containing more glass would be expected to absorb water and increase the water 
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uptake as loading amount of glass in the pellet increased. The increased water uptake by the 
composite pellets as compared to the controls would also mean that more material could be 
moved out of the pellet by water transport. 
The pH of the solutions rose as the glass particle diameter size decreased, which could be 
explained by the larger surface area of the smaller particles allowing for more interaction with 
the PBS and therefore quicker dissolution. 40% glass loadings consistently caused the highest pH 
values throughout the glass sizes, which was not surprising as more glass material would have 
been available for dissolution. The components that were released from the glass formed bases 
that would have increased the solution’s pH as the glass eluted.55 
Of the elements tested, boron consistently had the highest concentration in solution over 
time. This was expected because boron composes most of the glass and remains in solution 
without forming compounds with other elements, such as calcium and phosphorus. Increases in 
pH have been shown to increase the corrosion of borate bioactive glasses, and so the rise in 
boron concentration as the pH rose was anticipated.97  
Magnesium concentrations also increased over time in solution, but compared to its 
relative concentration in the glass’s formula to boron, less magnesium than would be anticipated 
had eluted from the composites. Borate glasses are assumed to dissolve congruently, and the 
most likely reason for the magnesium deficiency in the solution was due to its incorporation into 
the precipitate.98 Notably, the magnesium product from degradation (Mg(OH)2) is not soluble in 
water, which could cause magnesium to join the precipitate instead of the solution.99 More 
magnesium came out of the solution for 5 µm samples than for 100 µm samples. This could 
mean that more precipitate formation was occurring in the 5 µm samples, which would provide 
more available material for magnesium to occupy. Likewise, the lower Mg/B ratio for 40% 
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loaded samples than for samples with less glass loading meant that 40% loaded samples 
underwent more precipitate formation. 
The normalized Mg/B ratios seen in Figure 2-7 are lower than the ratios seen in one study 
testing 13-93B3 dissolution.98 This is most likely because that study used a dynamic environment 
that prevented a buildup of ions, while here the samples remained in a static solution throughout 
the experiment. The lack of solution change would cause the magnesium in the solution to 
interact with the precipitate surfaces for longer, therefore causing more magnesium ions to 
become incorporated into the forming precipitate. In another study, however, even less 
magnesium relative to boron was seen in solution than here, and this discrepancy could be 
explained by the different glass composition and solution volume used.99 
Phosphorus, despite being released from the glass, decreased in solution concentration 
over time because the phosphorus in solution was combining with the calcium dissolving from 
the glass to form calcium phosphate precipitates. As there was no calcium in the PBS (Table 2-
1), calcium was the limiting reactant for precipitate formation. 
 
2.6. Conclusion 
Having either more glass available in the composite or incorporating glass in a smaller 
particle size appeared to cause higher glass dissolution, which raised the pH and boron 
concentrations and caused more precipitate to form. The mechanical properties of the cements 
tested here were not reduced enough to be considered unsuitable for loading applications. This 
suggests that the glass composites in this work could be used similarly to plain SmartSet MV 
while also providing material for bone growth and potential antibiotic delivery. 
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One limitation of the experimental design is that the samples were soaked in vitro without 
replacing the solution throughout the duration of the experiment. Therefore, this study more 
closely reflects the event that the glass’s eluted material can accumulate in a space close to the 
samples. In an in vivo environment, the ions would be circulated away by the body, lessening the 
ionic concentrations and possibly increasing the degradation rate of the glass through Le 
Chatelier’s principle.58 
The samples used here were also vacuum-mixed during preparation to further control the 
physical properties of the pellets. Vacuum-mixing removes excess voids from the cement, and 
this was meant to minimize the chance that the cement would fall below the compressive 
strength ASTM standard; however, the compressive strengths of all composites studied were 
higher than the ASTM standard. Forming equivalent cement mixtures outside of a vacuum 
environment and testing them in the same way done in this work would investigate if cement 
with a higher porosity could also retain a compressive strength above 70 MPa. More of such 
pores would be advantageous for glass dissolution by allowing more water volume into the 
pellets and creating more exits for the glass’s material, which would further increase the amount 
of material eluted. 
Future directions include increasing the sample sizes for the experimental tests and 
lengthening the time points studied to see if the trends persist. The data here could be used to 
form a power analysis for the sample size in future work. More specifications in the ASTM F451 
guidelines could also be tested, such as the maximum exothermic temperature of the composites 
when curing, the setting times of the composites, and the amount of residual monomer left after 
curing. ISO 5833 also has additional guidelines for the mechanical strength of acrylic bone 
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cement that could be tested for these composites, such as a minimum bending strength of 50 
MPa and a minimum bending modulus of 1800 MPa. 
13-93B3 could be mixed with other commercial bone cements to test the effect of 
differing composite matrices, and antibiotics such as vancomycin and gentamicin can be added 
alongside 13-93B3 to see how this glass formulation affects their elution rate in cement. The 
amount and rate of antibiotic elution can be compared between composite groups and bone 
cement controls, and the effectiveness of the incorporated antibiotic at suppressing bacteria 




Chapter 3: Characterization of the Conversion of Bone Cement and Boron-Based Bioactive 
Glass Composites  
3.1. Abstract 
Borate bioactive glass 13-93B3 can convert into a hydroxyapatite-like material within the 
body, which can be helpful to attract bone growth around implants such as bone cement and 
prevent biofilm formation. In this study, 13-93B3 was incorporated into the commercial bone 
cement SmartSet MV, and the conversion of the glass into a precipitate was investigated with 
visual inspection via scanning electron microscopy (SEM) as well as with energy dispersive X-
ray spectroscopy (EDS), Fourier transform infrared (spectroscopy) – attenuated total reflection 
(FTIR-ATR), and micro-Raman spectroscopy. Glass particles 5 µm, 33 µm, and 100 µm in 
diameter were each mixed with the commercial bone cement SmartSet MV to create 20%, 30%, 
and 40% glass-loaded mixtures. The precipitate that formed on the samples was found to be a 
calcium-deficient apatite partially substituted with magnesium ions, which would mimic bone 
material better than stoichiometric hydroxyapatite. Composites of bone cement and 13-93B3 
show promise in encouraging bone formation on the surface of the bone cement, reducing areas 
where biofilms can form undetected by the body. Future studies could be carried out with bone 
cells in vitro and with bone in vivo to better simulate the human body’s environment. 
 
3.2. Introduction 
Biofilms are extracellular structures made by bacteria to protect them from the 
environment, and their formation around a prosthetic joint implant is a health concern because of 
the difficulty of removing them using antibiotics.24 When living in a biofilm, bacteria are up to a 
thousand times less susceptible to antibiotics than free-floating bacteria are.33 If these have 
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formed on the surface a prosthetic joint, the typical method of treatment is a joint revision 
surgery involving the removal of the implant along with surrounding bone and tissue.5 This is 
financially costly and negatively affects the patient’s quality of life by requiring further 
hospitalization and invasive procedures.5  
Biofilms can form upon the surfaces of implanted material such as bone cement because 
some infectious bacteria, such as Staphylococcus epidermidis, are attracted to the hydrophobic 
nature of acrylic bone cement.100,101 The patient’s immune system can also have difficulty 
reaching the cement surface due to a lack of proper tissue adhesion to the cement, and this 
difficulty would be exacerbated by comorbidities that already hinder the immune system.5,37,72 
While loading antibiotics into implanted bone cement can temporarily suppress bacteria from the 
surrounding area, the initial strong release of antibiotics is short-lived.28 Low concentrations of 
antibiotics eluted afterwards can allow bacteria to develop an antibiotic resistance and eventually 
colonize the bone cement.32 
One potential way to combat biofilm formation is to use bioactive glasses, which have 
the ability to convert into hydroxyapatite that can attach to nearby tissues and attract growth 
from surrounding bone.42,43 The first bioactive glass formulation devised was Bioglass 45S5, 
created by Dr. Larry Hench in 1969 at the University of Florida.50 Another silicon-based 
bioactive glass formulation, 13-93, is more easily manufactured and is approved to be used in 
vivo in Europe.52,53 13-93B3 is a borate-based bioactive glass manufactured in Mo-Sci, Corp. in 
Rolla, Missouri, that is derived from the formulation of 13-93 and replaces the SiO2 in the glass 
with B2O3 (Table 1-1).52,61 The mixture of tetrahedral [BO4] and trigonal planar [BO3] units in 
B2O3 is less durable than the tetrahedral units that make up SiO2, and so the borate-based 13-
93B3 breaks down faster and more completely than glass with a silicate matrix does.51,61,64 
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13-93B3 is composed of six oxides (Table 1). Boron trioxide (B2O3) makes up the 
majority of the glass’s weight. Boron has been found to dissolve faster than silicon from glass 
structures, and borate-based glass has also been found to react more completely in an in vitro 
physiological environment to convert into hydroxyapatite.61 Degradation is assisted by sodium 
and potassium in the glass, which are network modifiers. Sodium and potassium are hard acids 
that can stabilize the hard base BO4 electrostatically, and they break up the glass structure by 
encouraging BO4 units to form in the boron network alongside BO3 units.63 This adds 
imperfections to the structure of the matrix, which reduces its durability.51 Magnesium, another 
network modifier in the glass, is also an important element for bone growth and is added to 13-
93B3 as magnesium oxide (MgO).65 Calcium oxide (CaO) is also a network modifier. Both 
calcium oxide and phosphorus pentoxide (P2O5) contribute calcium and phosphorus ions, which 
make up calcium phosphate and contribute to the formation of hydroxyapatite.  
When 13-93B3 interacts with a physiological solution, Na+ first dissolves from the glass 
structure, and the solution degrades the B-O bonds.61 Ca2+ and PO43- from the glass as well as 
PO43- already in solution react to form a layer of amorphous calcium phosphate. Hydroxide 
anions (-OH) from the solution combines with the amorphous calcium phosphate layer to slowly 
crystallize the layer into hydroxyapatite. CO3- from the solution and magnesium from the glass 
can also become incorporated, changing the hydroxyapatite into a non-stoichiometric form.59,69 
If 13-93B3 is incorporated into bone cement and used as a part of a joint replacement, then the 
resultant hydroxyapatite-like products from the glass would help integrate the cement with 
adjacent bone and foster bone growth. This would further attach the cement to bone and reduce 
exposed surface area on the cement that bacteria can latch onto and form antibiotic-resistant 
biofilms.34,35,41 In one study, a silicate bioactive glass added to PMMA-based bone cement was 
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able to counteract the disruptions that PMMA caused to bone formation, so there is already a 
precedent for the benefits of combining bioactive glass and PMMA for bone growth.37 
Kamimura et al. compared the interfacial tensile strength of rabbit bone and commercial bone 
cement with and without silicate-based bioactive glass beads after four weeks of implantation.102 
In their experiment, bone cement that contained glass was found to have a higher bone-bonding 
strength than regular bone cement did. 
While the conversion of 13-93B3 scaffolds has already been studied in literature, mixing 
bone cement with 13-93B3 may affect the morphology and identity of the converted 
products.69,71 This paper examines the precipitate that collected on the surfaces of composites of 
13-93B3 and a commercial bone cement, DePuy SmartSet MV (DePuy, Warsaw, IN). The 
progression of the glass conversion will be visualized here using SEM, and the elemental and 
molecular character of the precipitate will be studied using several types of spectroscopy that 
report different information about the composition of the precipitate. EDS detects the relative 
amounts of elements at selected areas of samples. FTIR-ATR readings rely upon the change in 
the permanent dipole of a molecular bond, and Raman spectroscopy relies upon the change of the 
polarizability of bonds.103 Because the last two spectroscopies report molecular vibrations using 
different techniques (infrared absorption and Raman scattering), peaks that are strong in micro-
Raman spectroscopy may be weak in FTIR-ATR and vice versa, and so micro-Raman 







3.3. Materials and Methods 
3.3.1. Materials 
The pellets used in this chapter were made in the same way explained in Chapter 2 
(2.3.1., 2.3.2.1.). However, the time points for soaking were truncated to 0, 7, and 21 days. 
Samples that soaked for 7 or 21 days were dried in an oven at 90°C for one day. Pellets were 
kept in histological glass jars sealed with Parafilm until used for the tests outlined in this chapter. 
 
3.3.2. Methods 
3.3.2.1. Scanning Electron Microscopy 
Pellets from each group were sputter-coated with an 80:20 gold-palladium alloy and were 
then observed through SEM (Hitachi S-2700, Tokyo, Japan) equipped with a Quartz PCI digital 
capture (Quartz Imaging Corporation., Vancouver, Canada). Comparative pictures of the 
morphology of the reacted surfaces were taken with 150x and 1500x magnification with an 
accelerating voltage of 15 kV. 
 
3.3.2.2. Energy Dispersive X-ray Spectroscopy 
The atomic compositions of the pellet surfaces were observable through SEM (Tescan 
VEGA LMU, Brno, Czech Republic) equipped with EDS (Bruker Quantax XFlash 100, 
Billerica, MA). The accelerating voltage was 20 kV, and the working distance was 15 ± 1 mm. 
20% 5 µm and 40% 5 µm pellets soaked for 21 days that showed evident precipitate formation 
were studied with this technique. Three EDS readings from each group were averaged to 
determine the atomic elemental proportions of the precipitate seen on each surface. EDS 




3.3.2.3. Fourier Transform Infrared Spectroscopy – Attenuated Total Reflection 
FTIR-ATR (Fourier transform infrared (spectroscopy) – attenuated total reflection) was 
used to detect the molecular bonds present in samples using infrared spectra, and this technique 
was used because not enough precipitate formed on each sample to be able to be analyzed with 
transmission FTIR. A PerkinElmer Spectrum 400 FTIR Spectrometer (PerkinElmer, Waltham, 
MA) with a diamond GladiATR accessory (PIKE Technologies, Madison, WI) was used to 
measure this from the sample surfaces. Pellets were placed upon the diamond crystal on the ATR 
appliance with their smooth circular surface touching the crystal, and the pellets were pressed 
down to maximize the surface contact with the crystal and strengthen the reading. The crystal’s 
diameter was 3mm. The spectra were captured within the wavelength range of 400-4000 cm-1 
with a resolution of 4 cm-1, and representative spectra were the result of averaging 64 scans. The 
ATR readings were corrected using PerkinElmer’s Spectrum software, and a correction value of 
“1” was used to transform the spectra to become equivalent to transmission FTIR readings. 
FTIR spectra were collected from all groups. The spectra for the cement control after 0 
and 21 days of soaking was also collected, and the spectra of as-received 13-93B3 were collected 
using 5 µm-sized glass because that size would have the most surface area in contact with the 
crystal. 
 
3.3.2.4. Micro-Raman Spectroscopy 
A Horiba Jobin Yvon LabRam ARAMIS Micro-Raman microscope (Horiba, Kyoto, 
Japan) was used to collect Raman spectra of samples. To record spectra, a 623.81 nm HeNe laser 
was used in conjunction with a 10x microscope, and individual spectra samples were each 
collected for five seconds. The wavelength range studied was 400-1600 cm-1, and eight spectra 
were averaged for each group. Spectra were collected from an unsoaked control, a control soaked 
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for 7 days, as-received 100 µm glass particles, and 20% 5 µm, 40% 5 µm, 20% 100 µm, and 
40% 100 µm samples soaked for 7 and 21 days. Spectra baselines were corrected by using the 
polyfit function in MATLAB (The Mathworks, Inc., Natick, MA) to fit a third-order polynomial 
to the spectra that was then subtracted. 
 
3.4. Results 
For pellets containing 100 µm glass particles, the glass at the surface changed into an 
opaque white color after soaking that contrasted with the darker and more translucent appearance 
of the bone cement control. For pellets containing glass particles with smaller diameters than 100 
µm, the sides of the pellets became pitted and covered with white protrusions while soaking, 
which increased as the glass loading increased. Two photos of comparative examples, shown in 
Figure 3-1, were taken using a Canon EOS 7D (Canon, Tokyo, Japan). 
    
Figure 3-1: Left: From left to right, a 30% 5 µm pellet, a 30% 33 µm pellet, a 30% 100 µm pellet, and a control 
pellet. The samples were soaked for 7 days and were dried in an oven at 90°C for one day. Right: From left to right, 
a 20% 33 µm pellet, a 30% 33 µm pellet, a 40% 33 µm pellet, and a control pellet. The samples were soaked for 21 







3.4.1. Scanning Electron Microscopy 
A spherical-textured surface could be seen on the micrographs of a control (Figure 3-2). 
This is a property of commercial PMMA-based bone cement. In the picture, beads of pre-
polymerized methyl methacrylate/styrene co-polymers from SmartSet’s dry powder component 
are covered by PMMA, which polymerized around the beads when the cement cured.15,16,72 The 
white rounded flecks embedded in the surface is barium sulfate. 
 
Figure 3-2: SEM micrograph of a control sample soaked for 21 days. 







Through SEM micrographs, it is evident in Figure 3-3 that the shape of 13-93B3 particles 
used here are angular in nature and are covered with smaller chipped glass particles. The particle 
shapes are irregular due to the grinding methods used. 
 





Figure 3-4: Surfaces of samples containing 5 µm glass after soaking for 0, 7, and 21 days. 
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5 µm Composites: The inclusion of 5 µm glass into the dry pellets are evidenced by the jagged 
bumps under the PMMA layer in Figure 3-4, which increase in frequency as the concentration of 
glass increases.  
For 20% 5 µm, precipitates could be seen by Day 7, but surface coverage was sparse. 
Isolated areas showed small crystalline formations. By Day 21, the surface was covered with 
precipitate, and crystalline formations mixed with powdery precipitates could be seen.  
For 30% 5 µm, a crystalline morphology could be seen on the surface by Day 7, as well 
as a thin layer of precipitate. Some larger precipitate structures had formed, as seen in Figure 3-
5. By Day 21, the surface was more completely and thickly covered with larger precipitate 
particle sizes, and some craggy accumulations of precipitate were present. 
For 40% 5 µm, at Day 7 the surface already had rounded structures and was partially 
carpeted with granular particles, and by Day 21 the surface was more thickly carpeted. 
 
 











33 µm Composites: In Figure 3-6, glass is evidently embedded in the bone cement and covered 
with a layer of PMMA in dry samples. For 20% 33 µm, after 7 days of soaking, precipitate has 
accumulated on sporadic areas on the surface, and some large structures are present. By Day 21, 
precipitate with a granular morphology had extended to cover more surface area as well as a 
strand-like form seen in Figure 3-7. Crystalline platelet forms that existed on the analogous 20% 
5 µm pellets could not be seen.  
For 30% 33 µm, some calcium phosphate growths have formed by Day 7, but they are 
restricted to areas surrounding surface glass, where clumps of precipitate crystals have formed, 
including spheres and elongated strands. By Day 21, the clumped precipitates have spread out 
further onto the cement surface.  
For 40% 33 µm, by Day 7, large rounded precipitate structures had formed around 
surface pores, and the PMMA top layer was cleaved around the edges of embedded glass 
particles. By Day 21, the precipitate extended away from individual glass particles embedded in 
the matrix, and large precipitate structures had formed. The area surrounding these structures 
were carpeted with precipitate, including platelets and small spheres. 
 
 









100 µm Composites: Glass was consolidated into large particles, as seen in Figure 3-8, and for 
20% 100 µm, the particles were sparsely distributed on the surface. When the samples were 
formed, the glass near the surface was covered with polymerized PMMA. After 7 days, the bone 
cement layers surrounding the glass particles in 20% 100 µm had torn, which directly exposed 
the glass to the solution. The surface of the glass had become textured, with small clumps of 
material clinging along edges. Degradation and precipitation appeared to be concentrated upon 
glass particles, with little precipitation away from the glass.  
For 30% 100 µm, precipitation beyond the exposed glass was still sparse. By Day 7, the 
glass particles were showing signs of cleaving. By Day 21, the glass showed further signs of 
cleavage and degradation. The rounded clumps of precipitate on the glass were more prevalent 
and numerous in 30% 100 µm than in 20% 100 µm.  
For 40% 100 µm, by Day 7, precipitate accumulation extended beyond the areas of 
exposed glass particles, and glass cleavage was more pronounced than in other formulations with 
100 µm glass after the same amount of soaking time. Thin needles and platelets were evident. By 
Day 21, granular precipitate with strand-like protrusions surrounded the degraded glass and 
covered nearby surfaces. Large precipitate structures were also present. 
For pellets containing glass particle sizes of 5 µm or 33 µm, rounded and concave 
accumulations of precipitate also formed upon the surface, as seen in Figures 3-5 and 3-9. The 
structures tended to be situated above a surface pore, and the PMMA-covered surface of the 




Figure 3-9: Left: Precipitate structures on 40% 33 µm after 7 days of soaking. Right: Precipitate structures on 30% 
5 µm after 21 days of soaking. 
 
3.4.2. Energy Dispersive X-ray Spectroscopy 
3.4.2.1. Elemental Ratios 
The values found for calcium, magnesium, and phosphorus concentrations are shown in 
Table 3-1. While the Ca/P ratios were lower than the 1.67 Ca/P ratio seen in stoichiometric 
hydroxyapatite, (Ca+Mg)/P ratios for 20% 5 µm and 40% 5 µm pellets soaked for 21 days 
approached 1.67.  
The related EDS spectra are shown in Figure 3-10. The differences between 40% 5 µm 
and 20% 5 µm are not notable. The Cl peaks are attributable to the chlorine present in the PBS 
(Table 2-1), and the Al and Si peaks are negligible and likely from the environment. 
Sample Ca (mol%) P (mol%) Mg (mol%) Ca:P (Ca+Mg):P Ca:Mg 
20% 5 µm 7.81 ±  0.26 6.21 ± 0.29 2.77 ± 0.19 1.26 1.70 2.82 
40% 5 µm 8.95 ± 0.51 7.02 ± 0.38 3.42 ± 0.3 1.27 1.76 2.62 





Figure 3-10: Representative EDS spectra for a 20% 5 µm sample soaked for 21 days (A) and a 40% 5 µm sample 
soaked for 21 days (B). 
 
 
3.4.2.2. Elemental Mapping 
Through elemental mapping seen in Figure 3-11, the precipitate upon a 20% 5 µm pellet 
soaked for 21 days was found to have an increased amount of calcium, phosphorus, and 
magnesium and lack carbon, sulfur, and barium relative to the surrounding surface. Oxygen was 

















Figure 3-11: The original SEM micrograph of a ring of precipitate (1) and a corresponding EDS elemental analysis 
map of all elements studied combined (2), oxygen (3), calcium (4), carbon (5), phosphorus (6), barium (7), 
magnesium (1), and sulfur (9). The micrographs are from a 20% 5 µm pellet soaked for 21 days. Dark regions in (1) 
is thermal damage from the SEM technique used. All maps were evenly brightened in Adobe Photoshop CC 2017 to 
better illustrate the colors. 
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3.4.3. Fourier Transform Infrared Spectroscopy – Attenuated Total Reflection 
Graphs comparing the FTIR data of the control and unconverted 13-93B3 glass with 
glass-containing samples are shown in Figure 3-12, and the peak assignments are detailed in 
Table 3-2. The control shown was soaked for 21 days; an unsoaked control (not shown) provided 
a spectrum nearly indistinguishable from the soaked control. The strongest peak, at 1726 cm-1, 
was from the C=O stretch in the ester group in PMMA.105  
The glass powder showed broad peaks at 1360 cm-1 and 715 cm-1, which were indicative 
of B-O stretching and bending in BO3 groups respectively, and a peak at 950 cm-1 showed B-O 
stretching in BO4 units.87,106 
The FTIR spectrum recorded from the dry 5 µm 20% sample had weaker versions of the 
control’s peaks. The dry 30% and 40% 5 µm spectra had even weaker peaks. A peak from 950-
1100 cm-1 centered at approximately 1030 cm-1 was noted after 21 days in all 5 µm samples, and 
this peak was attributed to PO43-. The 560 cm-1 peak was less evident in 33 µm samples and 
appeared as a shoulder instead, which became more prominent as soak time increased and as 
glass concentration increased. The ν4 PO43- peak at 603 cm-1 was overlapped by the SO42- peak at 
608 cm-1 and was therefore difficult to see. Signs of CO32- peaks were not detected at 870-879 
cm-1, 1414 cm-1, 1455 cm-1, or 1545 cm-1, but, if present, may have been hidden by peaks caused 
by the bone cement’s components.107 For 5 µm samples, a broad band at 3000-3500 cm-1 
increased in intensity as the loading amount and soak time increased. For 100 µm-loaded 
samples, no notable changes were seen throughout the soak periods and glass concentration. The 




Figure 3-12: Representative FTIR-ATR spectra of samples containing 5 µm glass (A), 33 µm glass (B), and 100 µm 
glass (C). Samples soaked for 0 days are termed here as “dry”. The spectra for a control sample soaked for 21 days 
and for as-received 5 µm glass are presented here for comparison. Dotted lines designate peaks of interest explained 












Peak (cm-1) Assignment Reference 
480 w out-of-plane deformation of ester (ν6) 105 
556 m PO43- bending (ν4) 87 
603 m PO43- bending (ν4) 87 
608 m SO42- out-of-plane bending 109 
636 m SO42- out-of-plane bending 109 
704 w out-of-plane bending in phenyl group in styrene 110 
715 m b B-O bending in BO3 106 
748 m antisymmetric stretching of C-C skeletal mode 105 
840 w CH2 rocking 105 
912 w CH3 rocking 111 
950 s b B-O stretching in BO4 106 
964 m α-CH3 rocking 105 
984 m O-CH3 rocking 105 
1030 s PO43- antisymmetric stretching (ν3) 87 
1060 s antisymmetric stretching of C-C skeletal mode 105 
1112 s antisymmetric stretching of C-C skeletal mode 105 
1144 s C-O-C antisymmetric stretching 105 
1188 s C-O-C antisymmetric stretching 105 
1236 m C-O stretching 105 
1268 m C-O stretching 105 
1360 s B-O stretching in BO3 106 
1385 w symmetric bending of C-H in α-CH3 105 
1433 m sh symmetric bending of C-H in O-CH3 105 
1446 m symmetric bending of C-H in alpha CH3 105 
1480 m CH2 bending 105 
1724 s sh C=O stretching 105 
2848 m combination band involving O-CH3 105 
2920 s combination band involving O-CH3; symmetric stretching of CH2 105 
2948 s symmetric stretching of C-H in α-CH3 and in O-CH3; antisymmetric stretching of CH2 
105 
2992 m antisymmetric stretching of C-H in α-CH3 and O-CH3 105 
3000-3500 m b absorbed H2O 112 
Table 3-2: Peak assignments for the FTIR-ATR spectra shown in Figure 3-12. For peak characteristics, w = weak, 









3.4.4. Micro-Raman Spectroscopy 
Raman spectra are shown in Figure 3-13 along with peak assignments in Table 3-3. The 
unsoaked control’s peaks correlated with literature values for PMMA, styrene, and barium 
sulfate. Immersing the control in PBS appeared to cause changes to the peaks. Peaks at ~670 and 
~760 cm-1 were introduced after a week of soaking and were considered to be recording artifacts. 
These artifacts near 500 cm-1 shielded the C-C-O peak at 486 cm-1 from view. 
The glass mixtures presented peaks that are seen from the soaked control, but the peaks at 
602, 812, 972, 987, 1004, and 1457 cm-1 from the bone cement have been decreased. The 
sharpness of the ν1 PO43- peak at 964 cm-1 appeared to decrease relative to other peaks from 7 






Figure 3-13: Raman spectra obtained from various surfaces: a control soaked for 0 days, a control soaked for 7 
days, and as-received 100 µm glass (A); 20% 5 µm and 40% 5 µm after 7 and 21 days of soaking (B); and 20% 100 










Peak (cm-1) Assignment Reference 
486 w C-C-O out-of-plane deformation 105 
594 w PO43- bending (ν4) 113 
602 s C-C-O symmetric stretch (ν1) 114 
616 m SO42- out-of-plane bending 115 
812 s sh C-O-C symmetric stretch 114 
849 w CH2 rocking 105 
964 s PO43- symmetric stretching (ν1) 113 
972 m sh α-CH3 rocking 105 
987 s sh SO42- symmetric stretch 115 
1004 m sh aromatic breathing mode of styrene 116 
1033 w C-H bending in aromatic ring of styrene 116 
1110 w skeletal C-C antisymmetric stretch 105 
1128 w C-O-C antisymmetric stretch 105 
1190 w C-O-C antisymmetric stretch 105 
1204 w C-C stretch in styrene 117 
1238 w C-O stretch 105 
1330 w CH2 wagging 117 
1393 w symmetric bending of C-H in α-CH3 105 
1457 s CH2 bending 117 
1489 m CH2 bending 105 
Table 3-3: Peak assignments for the Raman spectra shown in Figure 3-13. For peak characteristics, w = weak, m = 
medium, s = strong, sh = sharp. The highlighted peak assignments are the identifying peaks used for hydroxyapatite. 
 
3.5. Discussion 
Overall, the thin layer of PMMA that covered surface glass particles formed cracks as the 
samples soaked. This may have been due to pressure exerted onto the PMMA layer by the 
dissolving glass. The coatings of precipitate that formed on the surfaces were typically sporadic 
and uneven, and this was likely due to the heterogeneity of the cement causing differing local 
concentrations of glass. The morphology of the precipitate was also affected by the size and 
concentration of glass added. Having more glass in the composite and in a smaller particle size 
appeared to allow the glass to dissolve faster and more completely, forming more widespread 
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precipitation. On bone cement containing 100 µm glass, more crystallized hydroxyapatite formed 
on the surfaces of exposed glass particles. 
Solution pH appeared to affect the morphologies of the precipitate. In literature, 
hydroxyapatite formed in sheets at a solution pH of 7.5, and at a high pH such as 10, amorphous 
calcium phosphate first formed rapidly around nucleation sites before crystallizing into 
hydroxyapatite, creating small particles.118 In Figure 3-4, 20% 5 µm samples have platelet-like 
crystalline precipitates, while the higher-loaded samples had more granular precipitate 
formations. From Figure 2-5a, for 5 µm samples, the 20% loading also had the most moderate 
pH values, culminating in an average pH of 8.63 after 21 days of soaking, while the 30% loading 
had a solution pH of 8.88 and the 40% loading had a solution pH of 9.13 by that time. Figures 3-
5 and 3-7 also show oriented precipitates that formed in environments with a finishing pH of 
8.79 and 8.47, respectively. For 100 µm samples, which maintained low pH values relative to 
other groups, the morphology was more orderly than in 5 µm samples, and this is reflected in the 
strong ν1 PO43- peaks seen in Figure 3-13c. Hydroxyapatite in the shape of plates, like those seen 
on 20% 5 µm samples at a relatively lower pH value, has been found in organic sources, such as 
bone.119 In the body, the fluid environment would be continuously flushed by the body, and so 
the precipitate morphologies seen at higher pH conditions may not form in vivo.120 
Bowl- and ring-shaped structures of precipitate, such as those seen in Figures 3-5, 3-9, 
and 3-11, may have formed around air bubbles that exited the samples after immersion and 
remained on the sample surfaces, providing a nucleation site. Such structures were interspersed 
on samples, and they likely formed in areas with greater-than-average amounts of glass to be 
able to accumulate enough material to create these structures. The surfaces immediately 
surrounding the structures were also covered with precipitate. The texture of this surrounding 
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precipitate, as seen in the close-up in Figure 3-5, is small and rounded, and this texture has been 
seen in hydroxyapatite deposits before.58,69 As with high pH values, these formations may not 
occur in in vivo versions of this study due to the dynamic environment within the body. 
The (Ca+Mg)/P ratios of the precipitates studied were close to 1.67, which would be 
expected for a magnesium-substituted hydroxyapatite arising from glasses doped with Mg.66 
However, the Ca/Mg ratios in the precipitates studied were high and the Ca/P ratios were low 
compared to values reported for precipitate on soaked 13-93B3 fibers.69 The magnesium may 
have become saturated in the solution used here, causing the excess to enter the precipitate and 
increase the Ca/Mg ratio. Bertinetti et al. had hypothesized about the formation of a thin layer of 
a magnesium-hydrated phase on apatite surfaces when in solutions of high magnesium 
content.121 Due to the low Ca/P ratios, the precipitate in the areas studied may have also still 
been in the process of transforming into hydroxyapatite, as magnesium ions slow down 
conversion.122 On the elemental mapping, the calcium, oxygen, phosphorus, and magnesium 
amounts are higher on the precipitate than on the rest of the surface. This suggests that the 
precipitate is made of a magnesium incorporated apatite, as would be predicted for a product of 
13-93B3.69 The precipitate contained less barium, sulfur, and carbon than the surrounding areas, 
which would be expected because the presence of these elements would represent areas of bone 
cement not covered by precipitate. Barium sulfate present in the bone cement formulation is 
composed of barium and sulfur, and carbon is a component of PMMA.  
From the FTIR-ATR data, representative spectra of the control showed peaks that 
correlated well with reported values for PMMA and barium sulfate. The broad quality of the ν3 
PO43- peak at 1030 cm-1 for 5 µm samples after 21 days of soaking indicated poorly crystallized 
hydroxyapatite, which would be expected due to the incorporation of magnesium.69,112,123 From 
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the same readings, the asymmetric bending frequency (ν4) of phosphate at 600 cm-1 split into a 
doublet at 556 cm-1 and 603 cm-1, which also indicated hydroxyapatite. As the glass 
concentration increased, the peaks became less distinct from each other. More separation 
between the peaks meant higher crystallization.124 Therefore, after 21 days of soaking the 20% 5 
µm sample appeared to have the most crystallized hydroxyapatite, with 30% 5 µm samples 
showing less crystallization and 40% 5 µm samples having even lower crystallization. The 5 µm 
glass findings were validated by the SEM results, which showed that platelets had formed on the 
20% 5 µm surface instead of the scattered powders seen in samples containing higher 
concentrations of 5 µm glass. The broad band also seen at 3000-3500 cm-1 in 5 µm samples was 
attributed to water, which would have been absorbed by the precipitate.112 This band would not 
be seen in samples with a surface area mainly composed of hydrophobic PMMA.  
FTIR-ATR spectra were collected from the smooth surfaces of the samples, and these 
surfaces formed when the samples were curing in PTFE molds. When the cement was packed 
against the sides of the mold, the polymerizing matrix filled in the space around fillers. Smooth 
sample surfaces did not have the beaded texture seen in the SEM micrographs taken, and so 
styrene peaks at 1493 cm-1 and 1603 cm-1 from C=C aromatic stretches and at 3026 cm-1 from C-
H aromatic stretches were not detected.125 This smoothness limited the surface area on the 
composites covered by larger glass particles (33-100 µm) and their precipitates, which in turn 
limited their expression on FTIR-ATR readings. 
In the Raman spectra, samples of 100 µm may have had a sharper peak at 964 cm-1 
because of the moderate pH and because the surface of the large glass particles would constantly 
interact with dissolving material from within the glass, causing more complete crystallization. 
The 100 µm samples also had a small peak near 594 cm-1 indicative of ν4 PO43-, just as seen in 
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FTIR data. The position of the ν1 PO43- peak is critical to differentiate the precipitate between 
various forms of calcium phosphate, and at 964 cm-1 as seen in Figure 3-13, this indicates 
hydroxyapatite. Shifts in this peak’s position would represent other forms. For example, a broad 
peak centered at 950 cm-1 would indicate amorphous calcium phosphate, with its broad quality 
resulting from the lack of crystallinity.126 If β-tricalcium phosphate was a prevalent form, peaks 
at 946-949 cm-1 and 971 cm-1 would be seen instead.127 
A substitution of calcium with magnesium in hydroxyapatite would cause changes to the 
bond lengths and the matrix structure of the material, as magnesium is a smaller ion.128,129 This 
partial substitution increases the disorder of the crystallinity of the hydroxyapatite, lowering the 
intensity of PO43- spectra and increasing the peak width.130 Because the 964 cm-1 peak broadens 
as the amount of magnesium rises, it is possible that the precipitate on the samples incorporated 
more magnesium over time, as seen in 40% 100 µm, and that 5 µm samples incorporated more 
magnesium than 100 µm samples did. A lack of crystallinity may also come from the small size 
of the precipitate particles, which were seen with SEM. Raman spectra did not differ noticeably 
between samples containing 5 µm glass soaked for 7 days and 21 days. 
The ν1 PO43- peak at 964 cm-1 was the most reliable indicator of a phosphate-based 
precipitate in the Raman spectra; other related phosphate peaks were not visible, aside from 
weak ν1 PO43- peaks in 100 µm samples at 594 cm-1. Other peaks that could have been present, 
such as ν2 or ν3 PO43-, were not visibly identified and may have been shielded by the peaks seen 
in the Day 7 control. The broad peak near 960 cm-1 in all composite spectra was not considered 
to be conclusive for amorphous calcium phosphate because the peak was not centered around 
950 cm-1 and had appeared to be present in the spectra of the Day 7 control. However, it is noted 
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that magnesium ions in the precipitate can help stabilize amorphous calcium phosphate and slow 
down its conversion process to hydroxyapatite.122 
Micro-Raman peaks differed from FTIR-ATR peaks because some molecular vibrations 
are more Raman-active than IR-active and vice versa.103 The Raman spectra were also directly 
sampled from spots on exposed glass, which differed from the FTIR-ATR technique of scanning 
a large and smooth surface area. FTIR-ATR could detect precipitate bonds as long as the 
precipitate covered enough surface area to overcome the bone cement spectra, but the micro-
Raman technique collected spectra from small, isolated areas of precipitate. 
 While the incorporation of magnesium into hydroxyapatite lowers its crystallinity, this 
ionic addition would be beneficial for bone growth and attachment around the material. 
Biological hydroxyapatite contains ionic substitutions for calcium, which means that the 
magnesium-substituted hydroxyapatite identified in this study would better mimic natural apatite 
than would stoichiometric hydroxyapatite.131 Human bone already contains 0.47 wt.% of 
magnesium, and this similarity to natural bone material could boost its osteoconductivity.66,70 
Magnesium encourages osteoblast formation for bone building, which would help regrow bone 
lost during a joint replacement surgery.65 The presence of magnesium has been shown to improve 
the attachment of living bone onto surfaces, which would help further attach the composites 
studied here to surrounding bone and reduce the surface area on the cement that living tissue 








The precipitate that accumulated on the composites was concluded to be a 
hydroxyapatite-like mineral that included substitutions of magnesium ions in place of calcium. 
Magnesium incorporated in the precipitate layer on the surface of the cement could increase the 
success of bone growth around the cement. This would help better attach the bone cement and 
connected implants onto the native bone, recoup bone removed during surgery, and reduce the 
surface area on the bone cement that is open to biofilm formation. 
One limitation of this study was the sample size used for SEM-EDS readings. The EDS 
elemental map in Figure 3-11 is from mapping one sample, and in the future, EDS mapping 
could be expanded to track the progression of elemental distributions over time spent soaking for 
more groups to compare them. The groups studied in the EDS and micro-Raman tests could be 
expanded as well to include data from 33 µm groups and for soak lengths besides 7 and 21 days. 
This would give further insight into the precipitate formation process and show if any other 
phases of calcium phosphate had formed during the soaking interval. The various morphologies 
seen under SEM may also have different ratios of Mg, Ca, and P, which could be studied by 
collecting further EDS data from these groups. 
A weakness of the FTIR-ATR technique used here is that the spectra become noisy at 
wavelengths less than 650 cm-1, so data at higher wavelengths should be considered to be more 
reliable. Another limitation of this technique is that a smooth surface on the samples was used to 
collect FTIR spectra due to its increased ability to interface with the crystal surface, which 
misses information about the rough sides of the samples and their rounded sides.  
Analyzing pure PBS with micro-Raman spectroscopy may help locate the source of the 
unidentifiable peaks that appeared in soaked samples in Figure 3-13. The resolution of the micro-
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Raman data could also have been improved by using a more powerful magnification, such as 
100x, and by collecting the data for longer than five seconds at a time.  
X-ray diffraction (XRD) could be utilized as an added measure of the crystallization of 
the precipitates. Studying the angles of diffraction caused by the precipitate would further 
confirm the identity of the species forming on the sample surfaces over time. This would be 
another way to discern between various forms of calcium phosphate and hydroxyapatite and their 
crystallinity. Due to the poorly crystallized forms of hydroxyapatite seen on composites with 
higher loading amounts, this technique would be most effective for composites with a 20% glass 
loading. 
Some samples, such as the 40% 33 µm pellet in Figure 3-1, were markedly more porous 
on their rounded sides than the controls were. Further studies can measure the porosity of these 
samples and take SEM images of surface locations not studied here. Samples can also be cut 
width-wise to examine their cross sections and see how far inwards the pores penetrate the 
samples. EDS and micro-Raman spectroscopy spectra from precipitate inside the of pores can be 
analyzed to see how precipitate in these locations may differ in composition from surface 
precipitate.  
The extent of possible bone cell proliferation on the composites could be tested in vitro to 
make sure that the precipitate does in fact encourage bone growth more than the commercial 
bone cement control. If successful, then this test could be continued in vivo in a rat model as has 






Chapter 4: Thesis Conclusion and Future Directions 
Borate bioactive glass particles of 13-93B3 can be mixed into SmartSet’s dry powder 
component before polymerization to achieve noticeable changes in the properties of the cured 
product while not compromising the mechanical integrity of the cement. Changing the amount 
and particle size of 13-93B3 in the bone cement composite affected the bone cement’s 
compressive strength, though this value did not fall below the ASTM and ISO minimum 
standards. The weight loss and water uptake were also found to increase with the addition of 
bioactive glass. However, this did not exceed 1.5% and 6%, respectively, which helped to 
preserve the mechanical strength of the composites. The pH and boron ionic concentration in 
solution increased in pH as the glass in the composites continued to dissolve and enter the 
solution, which was expected. After soaking, a white precipitate was visible on the surfaces of 
the composite samples, and this was especially evident and widespread on 5 µm samples. The 
precipitate became increasingly amorphous and granular as the glass loading increased. This was 
due to the incorporation of magnesium, which is an element that further encourages bone growth 
and therefore increases potential bone attachment to the cement. 
Of the groups tested in this work, samples with a small glass particle size (5 µm) and a 
loading of 30-40% seemed to be the most effective at forming a precipitate layer incorporated 
with magnesium while maintaining the mechanical requirements of clinically-used bone cement. 
While these groups caused a high pH and boron concentration in the solution, this would be 
flushed away in vivo and not be a significant concern.  
Because the borate bioactive glass in the composites showed signs of dissolving and 
forming precipitate while the composites remained above ASTM and ISO standards for 
compressive strength, it can be concluded that composites of bone cement and borate bioactive 
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glass 13-93B3 could be used in applications for commercial bone cement while also providing 
material for bone ingrowth and potentially increasing antibiotic delivery. The most direct next 
step is to incorporate antibiotics, such as vancomycin and gentamicin, into the bioactive glass 
and bone cement composites. The elution rates of the antibiotic and its effectiveness at 
suppressing bacteria in vitro could then be studied. Since the addition of antibiotics may further 
affect the mechanical properties of the composites, the mechanical integrity of the composites 
would have to be monitored again. Testing osteoblast viability on the composite surfaces would 
also be helpful to ensure that the composites would not adversely affect bone growth. 
Other commercial bone cements beyond SmartSet MV can also be tested for this 
application. Palacos R is another type of bone cement mentioned in Chapter 1 that has been 
studied for its ability to deliver antibiotics, for example. The incorporation of 13-93B3 and 
antibiotics into these bone cements may cause different mechanical changes and glass dissolution 
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Appendix 1-1: An extended version of Figure 2-1 showing the respective control data for 
compressive strength that the composites were compared against for statistical analysis. The 
lines intersecting the graphs correspond to 70 MPa, the minimum standard from ASTM F451 
and ISO 5833. A diamond (♦) represents a group that soaked for 20 days. A triangle (▲) 
represents a group of n=4. An asterisk (*) over composite data represents a significant difference 




Appendix 1-2: An extended version of Figure 2-2 showing the respective control data for 
Young’s modulus that the composites were compared against for statistical analysis. A diamond 
(♦) represents a group that soaked for 20 days. A triangle (▲) represents a group of n=4. An 





Appendix 1-3: An extended version of Figure 2-3 showing the respective control data for weight 
loss that the composites were compared against for statistical analysis. An asterisk (*) over 




Appendix 1-4: An extended version of Figure 2-4 showing the respective control data for water 
uptake that the composites were compared against for statistical analysis. An asterisk (*) 
represents a significant difference (p<0.05) from its respective control. 
 
